Approximately, 50% of AML patients do not have clonal chromosomal aberrations and categorize as a cytogenetically normal acute myeloid leukemia (CN-AML)   8 , whereas FLT3/ITD mutations present in 30-40% of patients with CN–AML. The gene discussed is FLT3; the disease is acute myeloid leukemia.